Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
May
17
2016
EU: Indemnifying Commercial Agents – “New Customers” Can Include Existing Customers, CJEU rules Squire Patton Boggs (US) LLP
Mar
12
2024
Japan’s New Draft Guidelines on AI and Copyright: Is It Really OK to Train AI Using Pirated Materials? Squire Patton Boggs (US) LLP
Jun
17
2016
Supreme Court Clarifies Standards Governing the Attorneys’ Fees Awards In Copyright Litigation Squire Patton Boggs (US) LLP
Jul
18
2016
Response to UK Department for Business, Innovation and Skills Call for Evidence on Restrictive Covenants Squire Patton Boggs (US) LLP
Sep
28
2016
EU – When Will Hyperlinks Be Unlawful? Squire Patton Boggs (US) LLP
Apr
29
2020
Cybercriminals Are Beginning to Master the Exploitation of Public Entities Squire Patton Boggs (US) LLP
Sep
29
2016
Reduced Design Fees for UK Design Protection in Effect from 1 October 2016 Squire Patton Boggs (US) LLP
May
22
2020
The Chinese Supreme People’s Court Intervenes on Patent Issues, with Focus on Pharmaceutical Experiments Squire Patton Boggs (US) LLP
Nov
2
2016
FTC Issues Study On Patent Assertion Entity Activity –Why Was It Silent on Competition And Can We Expect Enforcement Action? Squire Patton Boggs (US) LLP
Nov
7
2016
UK Copyright Infringement: ‘Fair Dealing’ in Digital World Squire Patton Boggs (US) LLP
Jul
17
2020
In Assessing Design Patent Infringement, The Devil Is In The Details Squire Patton Boggs (US) LLP
Jul
28
2020
Transfers of Personal Data Outside the EEA: Action Required for Pension Schemes Squire Patton Boggs (US) LLP
Aug
4
2020
The Latest Draft Amendments to the Chinese Patent Law Squire Patton Boggs (US) LLP
Feb
2
2017
Ninth Circuit’s Recent Patent Local Rules Amendments: Elevating Damages Considerations to Same Level as Infringement and Invalidity Contentions Squire Patton Boggs (US) LLP
Feb
13
2017
Recent District Court reliance on Federal Circuit’s Enfish / McRO decisions may signify trend for Alice/Mayo patent eligibility test Squire Patton Boggs (US) LLP
Aug
1
2017
Federal Circuit Finds Regeneron Transgenic Mouse Patent Invalid For Inequitable Conduct With Intent Inferred From Litigation Misconduct Foley & Lardner LLP
Mar
11
2015
Federal Circuit Limits Patent Exhaustion Doctrine for Complementary Technology Foley & Lardner LLP
Mar
25
2015
Federal Circuit Finds Disclaimer Based on “Object of Invention” Language Foley & Lardner LLP
May
12
2015
California Supreme Court Scrutinizes Reverse Payment ANDA Settlements Foley & Lardner LLP
Jun
2
2015
Supreme Court on Induced Infringement: Good-Faith Belief of Invalidity Not a Defense and Knowledge of Infringement Required Foley & Lardner LLP
Mar
17
2022
PTAB Precedential Decision Clarifies When a Wire Transfer “Payment Is Received” by the Board Foley & Lardner LLP
Jun
30
2015
Examination Delay Earns Patent Term Adjustment Only In One Application Foley & Lardner LLP
Jul
14
2015
Contract Manufacturing Makes Angiomax Patents Invalid Under On Sale Bar Foley & Lardner LLP
Jul
16
2015
Attacking Patents on Written Description & Enablement Grounds in Inter Partes Review Foley & Lardner LLP
Dec
19
2017
Federal Circuit Finds Preemption Of State Law Penalty For Sitting Out Biosimilar Patent Dance Foley & Lardner LLP
Jul
19
2022
USPTO Proposes To Require Form For IDS PTA Safe Harbor Foley & Lardner LLP
Feb
16
2018
Federal Circuit: Pre-IPR Institution Disclaimer of Claims Insufficient to Avoid Adverse Judgment Foley & Lardner LLP
Oct
3
2022
UPSTO Extends Pilot Programs Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins